7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... mucoadhesive buccal tablet ... chew, or crush tablet ... Prevention #Treatment #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Performance thorough ... Stable patients ... surgery Stress Testing ... preoperative stress testing ... medical and surgical management
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Preventing and Treating ... with ARV (see Table ... Histoplasmosis #IDSA ... Prevention #Treatment #management
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
Performance Characteristics ... Tests #comparison #table ... #management #gastroenterology ... #CRC #Testing
ACA Colorectal Cancer Screening Guidelines

When to Screen?
When to Stop?
Family History

Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based
Family History Performance ... Tests #comparison #table ... #management #gastroenterology ... #CRC #Testing #
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Preventing and Treating ... please refer to Table ... AviumComplex #MAC #IDSA ... Prevention #Treatment #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for Treating Mycobacterium ... Please refer to the table ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management